• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neutralizing Epitopes and Residues Mediating the Potential Antigenic Drift of the Hemagglutinin-Esterase Protein of Influenza C Virus

tetano

Editor, Senior Moderator
Viruses. 2018 Aug 9;10(8). pii: E417. doi: 10.3390/v10080417.
[h=1]Neutralizing Epitopes and Residues Mediating the Potential Antigenic Drift of the Hemagglutinin-Esterase Protein of Influenza C Virus.[/h] Matsuzaki Y[SUP]1[/SUP], Sugawara K[SUP]2[/SUP], Furuse Y[SUP]3,[/SUP][SUP]4[/SUP], Shimotai Y[SUP]5[/SUP], Hongo S[SUP]6[/SUP], Mizuta K[SUP]7[/SUP], Nishimura H[SUP]8[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] We mapped the hemagglutinin-esterase (HE) antigenic epitopes of the influenza C virus on the three-dimensional (3D) structure of the HE glycoprotein using 246 escape mutants that were selected by a panel of nine anti-HE monoclonal antibodies (MAbs), including seven of the C/Ann Arbor/1/50 virus and two of the C/Yamagata/15/2004 virus. The frequency of variant selection in the presence of anti-HE MAbs was very low, with frequencies ranging from 10[SUP]-4.62[/SUP] to 10[SUP]-7.58[/SUP] for the C/Ann Arbor/1/50 virus and from 10[SUP]-7.11[/SUP] to 10[SUP]-9.25[/SUP] for the C/Yamagata/15/2004 virus. Sequencing of mutant HE genes revealed 25 amino acid substitutions at 16 positions in three antigenic sites: A-1, A-2, and A-3, and a newly designated Y-1 site. In the 3D structure, the A-1 site was widely located around the receptor-binding site, the A-2 site was near the receptor-destroying enzyme site, and the Y-1 site was located in the loop on the topside of HE. The hemagglutination inhibition reactions of the MAbs with influenza C viruses, circulating between 1947 and 2016, were consistent with the antigenic-site amino acid changes. We also found some amino acid variations in the antigenic site of recently circulating strains with antigenic changes, suggesting that viruses that have the potential to alter antigenicity continue to circulate in humans.


[h=4]KEYWORDS:[/h] antigenic structure; epidemiology; escape mutant; influenza C virus

PMID: 30096880 DOI: 10.3390/v10080417
Free full text
 
Back
Top Bottom